Elesclomol
CAS No. 488832-69-5
Elesclomol( STA-4783 | STA4783 | STA 4783 )
Catalog No. M14641 CAS No. 488832-69-5
Elesclomol (STA-4783) is a small-molecule oxidative stress inducer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 32 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 88 | In Stock |
|
| 50MG | 119 | In Stock |
|
| 100MG | 152 | In Stock |
|
| 200MG | 226 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElesclomol
-
NoteResearch use only, not for human use.
-
Brief DescriptionElesclomol (STA-4783) is a small-molecule oxidative stress inducer.
-
DescriptionElesclomol (STA-4783) is a small-molecule oxidative stress inducer, exerts selective cytotoxicity by increasing intracellular concentrations of reactive oxygen species (ROS) and induces cell death via mitochondrial apoptosisin cancer cells; selectively kills cisplatin-resistant tumor cells through increased ROS, markedly enhances the therapeutic index of paclitaxel against human tumor xenograft models. Ovarian Cancer Phase 2 Clinical.
-
In VitroApoptosis AnalysisCell Line:HSB2 cells Concentration:200 nM Incubation Time:18 hours Result:Increased the number of early and late apoptotic cells.
-
In VivoAnimal Model:Cardiac Ctr1 knockout mice Dosage:10 mg/kg Administration:Subcutaneous injection; every three days from post-natal day 5 to 26 and once weekly until post-natal day 54 Result:Ameliorated severe cardiac pathology with a partial reduction in hypertrophy.
-
SynonymsSTA-4783 | STA4783 | STA 4783
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorHSP70
-
Research AreaCancer
-
IndicationOvarian Cancer
Chemical Information
-
CAS Number488832-69-5
-
Formula Weight400.5177
-
Molecular FormulaC19H20N4O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 22 mg/mL
-
SMILESO=C(NN(C)C(C1=CC=CC=C1)=S)CC(NN(C)C(C2=CC=CC=C2)=S)=O
-
Chemical NamePropanedioic acid, 1,3-bis[2-methyl-2-(phenylthioxomethyl)hydrazide]
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Berkenblit A, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):584-90.
2. Kirshner JR, et al. Mol Cancer Ther. 2008 Aug;7(8):2319-27.
3. Wangpaichitr M, et al. Cancers (Basel). 2009;1(1):23-38.
4. Kluza J, et al. Cancer Res. 2012 Oct 1;72(19):5035-47.
molnova catalog
related products
-
SACLAC
SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
-
EC359
EC359 is a potent and selective inhibitor of leukemia inhibitory factor receptor (LIFR), a potent inhibitor with anticancer activity, blocks LIF/LIFR interaction, and can be used in the study of leukemia and endometrial cancer.
-
Ginsenoside Rg6
Ginsenoside Rg6 inhibits the proliferation and induces apoptosis of human lymphoma JK cells
Cart
sales@molnova.com